Literature DB >> 27865436

[Improving adverse drug reaction reporting by general practitioners through clinical research assistants visits].

Geneviève Durrieu1, Julien Jacquot2, Dominique Baudrin3, Mathilde Mège2, Vanessa Rousseau2, Haleh Bagheri2, Emmanuelle Bondon-Guitton2, Delphine Abadie2, François Montastruc2, Michel Bismuth4, Stéphane Oustric4, Jean-Louis Montastruc2.   

Abstract

The main limitation of adverse drug reactions (ADRs) reporting, particularly by general practitioners (GP), to the regional pharmacovigilance centers is under-reporting. The Midi-Pyrénées Regional Pharmacovigilance Center (South western, France) sets up regular visits by a clinical research assistant (CRA) to GP in order to increase the number of ADR reports. The aim of this pilot study was to assess the effect of regular visits of a CRA in GPs offices on the rate of ADR reporting. After one year, CRA visits permit a two-fold increase in ADR reporting.
Copyright © 2016 Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. All rights reserved.

Keywords:  Adverse drug reaction; Effet indésirable médicamenteux; General practitionners; Médecine générale; Pharmacovigilance; Pharmacovigilance network; Pharmacovigilance réseau; Sous-notification; Under-reporting

Mesh：

Year:  2016        PMID： 27865436     DOI： 10.1016/j.therap.2016.09.004

Source DB:  PubMed          Journal:  Therapie        ISSN： 0040-5957            Impact factor:   2.070


  2 in total

1.  Adverse Drug Reaction Reports Received Through the Mobile App, VigiBIP®: A Comparison with Classical Methods of Reporting.

Authors:  François Montastruc; Haleh Bagheri; Isabelle Lacroix; Christine Damase-Michel; Leila Chebane; Vanessa Rousseau; Emilie Jouanjus; Maryse Lapeyre-Mestre; Geneviève Durrieu; Jean-Louis Montastruc
Journal:  Drug Saf       Date:  2018-05       Impact factor: 5.606

2.  Completeness of Spontaneous Adverse Drug Reaction Reports Sent by General Practitioners to a Regional Pharmacovigilance Centre: A Descriptive Study.

Authors:  Geneviève Durrieu; Julien Jacquot; Mathilde Mège; Emmanuelle Bondon-Guitton; Vanessa Rousseau; François Montastruc; Jean-Louis Montastruc
Journal:  Drug Saf       Date:  2016-12       Impact factor: 5.606
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.